Author:
Dobrek Lukasz,Nalik-Iwaniak Klaudia,Arent Zbigniew
Abstract
Background:
Renal damage and dysfunction are possible complications of pharmacotherapy with ifosfamide (IF), which also manifests urotoxic properties. A routine drug used to reduce the risk of IF-induced cystitis is mesna. Compounds with effect expected to be similar to mesna include N-acetylcysteine (NAC).
Objective:
The objective of the paper was histopathological verification of the uroprotective effect of NAC and assessment of whether this effect is accompanied by a potential nephroprotective effect.
Methods:
The experiment was conducted on 3 groups: 1 – control, sham-treated rats, 2 – animals treated with 5 times the IF dose administered i.p. (50 mg/kg b.w.) and 3 – rats treated with 5 times the IF dose administered i.p. + NAC administered p.o. (200 mg/kg b.w.). The renal function was evaluated analysing classical and new protein parameters (cystatin C - CysC, kidney injury molecule-1 – KIM-1 and nephrin - NPH) in blood and urine. Furthermore, histopathological analysis of bladders and kidneys was carried out.
Results:
Treatment with IF resulted in the development of cystitis, with no significant histopathological disturbances in the kidneys, and caused an increase in concentration and 24-hour excretion of CysC, KIM-1 NPH in the urine. Additional NAC administration caused a reduction of the said biochemical disturbances as well as improvement of the histopathological image of the urinary bladders.
Conclusion:
The IF therapy caused cystitis and kidney dysfunction of functional tubulopathy and early glomerulopathy character. Additional administration of NAC entailed improvement in the urinary bladder morphology and renal function. NAC is, thus, a compound exerting both uro- and nephroprotective effects.
Publisher
Bentham Science Publishers Ltd.
Reference44 articles.
1. Perazella MA.
Pharmacology behind common drug nephrotoxicities.
Clin J Am Soc Nephrol
2018;
13
(12)
: 1897-908.
2. Dhodi DK, Bhagat SB, Pathak D, Patel SB.
Drug-induced nephrotoxicity.
Int J Basic Clin Pharmacol
2014;
3
(4)
: 591-7.
3. Yang B, Xie Y, Guo M, Rosner MH, Yang H, Ronco C.
Nephrotoxicity and Chinese Herbal Medicine.
Clin J Am Soc Nephrol
2018;
13
(10)
: 1605-11.
4. Han J, Xian Z, Zhang Y, Liu J, Liang A.
Systematic overview of aristolochic acids: nephrotoxicity, carcinogenicity, and underlying mechanisms.
Front Pharmacol
2019;
10
: 648.
5. Małyszko J, Kozłowska K, Kozłowski L, Małyszko J.
Nephrotoxicity of anticancer treatment.
Nephrol Dial Transplant
2017;
32
(6)
: 924-36.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献